Description
This podcast is based on the recent investor presentation by Biotech Growth Trust PLC. The podcast discusses the current state of the biotech market, highlighting the underperformance of small-cap biotech companies in recent years due to factors like rising interest rates. The podcast also focuses on key developments in biotech, including recent drug approvals and promising new technologies, and provides examples of successful biotech companies within the trust's portfolio.
This podcast is based on the recent investor presentation by Cambridge Nutritional Sciences PLC's (CNS) a UK-based personalized health company. The podcast highlights strong financial performance, including improved cash reserves and profitability. The podcast also focused on strategic growth...
Published 11/21/24
This podcast is based on the recent investor presentation by Fusion Antibodies PLC and covers the company's performance in the first half of fiscal year 2025. Key highlights include a 123% increase in revenue, driven by a revamped commercial strategy focusing on early client engagement and...
Published 11/21/24